RecruitingNot ApplicableNCT05896800

A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Inhaled Nitric Oxide in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease: a Prospective, Single-center Clinical Trial


Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment

24 participants

Start Date

Jun 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the influence of exercise capacity and safety of iNO at doses of 10 ppm or 40 ppm for 2 hours per day after continuous treatment for one week, which is of great significance for finding safe and effective methods for treating COPD.


Eligibility

Min Age: 40 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing inhaled nitric oxide — a gas delivered directly to the lungs — as a treatment for people with moderate to severe COPD (chronic obstructive pulmonary disease, a serious lung condition). **You may be eligible if...** - You are between 40 and 75 years old - You have a smoking history of at least 10 pack-years and have not smoked for at least one month - You have moderate to severe COPD confirmed by breathing tests - You are able to provide informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You currently use nicotine products (patches, etc.) - You have asthma or another non-COPD lung disease - You had a COPD flare-up requiring oral steroids in the past month - Your heart's pumping function is reduced (ejection fraction below 50%) - You have significant heart valve disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInhaled nitric oxide (NO)

The Nitric Oxide Generation and Delivery System is used to deliver nitric oxide for inhalation therapy into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user, to the patient throughout the inspired breath.

OTHERair

use air(21%O2)as the placebo of inhaled treatment


Locations(1)

The First Affiliated Hospital with Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05896800


Related Trials